comparemela.com

Latest Breaking News On - Shorla pharma - Page 1 : comparemela.com

SH-105 Gets Accepted for FDA Review in Breast and Ovarian Cancer

The FDA has announced that it had accepted the new drug application for SH-105 for the treatment of patients with breast and ovarian cancer.

Shorla wins FDA approval for leukaemia drug

Clonmel-headquartered Shorla specialises in developing innovative oncology drugs, with a focus on orphan and paediatric cancers.

Four companies listed for Irish Times Local Enterprise of the Year award

Euronext Dublin 2022 IPOready Programme Gets Underway

<p><span>Euronext Dublin&rsquo;s fourth edition of IPOready, a strategic financing programme for high-growth companies exploring fundraising options up to and including IPO, launched today with nine companies commencing the six-month long programme. The objective of the programme is to equip participating companies with an in-depth understanding of all sources of finance available to them and determine which is most suited to their needs. On completion, the participating founders and entrepreneurs will have the skillsets required to get their businesses investment ready, refine their pitch for investors and form a valuable network of peers, advisors and investors.&nbsp;</span></p>

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.